These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 26719680)

  • 1. Drug holidays: the most frequent type of noncompliance with calcium plus vitamin D supplementation in persistent patients with osteoporosis.
    Touskova T; Vytrisalova M; Palicka V; Hendrychova T; Fuksa L; Holcova R; Konopacova J; Kubena AA
    Patient Prefer Adherence; 2015; 9():1771-9. PubMed ID: 26719680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of Non-adherence to Supplementation with Calcium and Vitamin D in Persistent Postmenopausal Women Are Similar at Start and 1 Year Later: A Qualitative Longitudinal Study.
    Touskova T; Vytrisalova M; Palicka V; Hendrychova T; Chen YT; Fuksa L
    Front Pharmacol; 2016; 7():339. PubMed ID: 27746732
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiretroviral medication compliance in patients with AIDS.
    Frick PA; Gal P; Lane TW; Sewell PC
    AIDS Patient Care STDS; 1998 Jun; 12(6):463-70. PubMed ID: 11361994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-reported compliance with osteoporosis medication-qualitative aspects and correlates.
    Vytrisalova M; Blazkova S; Palicka V; Vlcek J; Cejkova M; Hala T; Pavelka K; Koblihova H
    Maturitas; 2008; 60(3-4):223-9. PubMed ID: 18774663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistance and Compliance with Osteroporosis Therapies Among Women in a Commercially Insured Population in the United States.
    Cheng LI; Durden E; Limone B; Radbill L; Juneau PL; Spangler L; Mirza FM; Stolshek BS
    J Manag Care Spec Pharm; 2015 Sep; 21(9):824-33, 833a. PubMed ID: 26308229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of compliance with naltrexone in the treatment of alcohol dependence: research and clinical implications.
    Namkoong K; Farren CK; O'Connor PG; O'Malley SS
    J Clin Psychiatry; 1999 Jul; 60(7):449-53. PubMed ID: 10453799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electronic monitoring of compliance to lipid-lowering therapy in clinical practice.
    Schwed A; Fallab CL; Burnier M; Waeber B; Kappenberger L; Burnand B; Darioli R
    J Clin Pharmacol; 1999 Apr; 39(4):402-9. PubMed ID: 10197299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of calcium co-medication in bisphosphonate therapy of osteoporosis: an approach to improving correct intake and drug adherence.
    Ringe JD; van der Geest SA; Möller G
    Drugs Aging; 2006; 23(7):569-78. PubMed ID: 16930085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of electronic monitoring (MEMS) to evaluate antipsychotic compliance in outpatients with schizophrenia.
    Remington G; Kwon J; Collins A; Laporte D; Mann S; Christensen B
    Schizophr Res; 2007 Feb; 90(1-3):229-37. PubMed ID: 17208414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase IV, two-armed, randomized, cross-over study comparing compliance with once-a-month administration of vitamin D3 to compliance with daily administration of a fixed-dose combination of vitamin D3 and calcium during two 6-month periods.
    Bruyère O; Deroisy R; Dardenne N; Cavalier E; Coffiner M; Da Silva S; De Niet S; Reginster JY
    Osteoporos Int; 2015 Dec; 26(12):2863-8. PubMed ID: 26100413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measured versus self-reported compliance with doxycycline therapy for chlamydia-associated syndromes: high therapeutic success rates despite poor compliance.
    Bachmann LH; Stephens J; Richey CM; Hook EW
    Sex Transm Dis; 1999 May; 26(5):272-8. PubMed ID: 10333280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to Calcium and Vitamin D supplementations: results from the ADVICE Survey.
    Conti F; Piscitelli P; Italiano G; Parma A; Caffetti MC; Giolli L; Di Tanna GL; Guazzini A; Brandi ML
    Clin Cases Miner Bone Metab; 2012 Sep; 9(3):157-60. PubMed ID: 23289030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost and consequences of noncompliance to oral bisphosphonate treatment.
    Eisenberg DF; Placzek H; Gu T; Krishna A; Tulsi BB
    J Manag Care Spec Pharm; 2015 Jan; 21(1):56-65. PubMed ID: 25562773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Summary of AHRQ's comparative effectiveness review of treatment to prevent fractures in men and women with low bone density or osteoporosis: update of the 2007 report.
    Levis S; Theodore G
    J Manag Care Pharm; 2012 May; 18(4 Suppl B):S1-15; discussion S13. PubMed ID: 22716221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compliance with cyclosporine in adolescent renal transplant recipients.
    Blowey DL; Hébert D; Arbus GS; Pool R; Korus M; Koren G
    Pediatr Nephrol; 1997 Oct; 11(5):547-51. PubMed ID: 9323277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose frequency and dose interval compliance with multiple antiepileptic medications during a controlled clinical trial.
    Cramer J; Vachon L; Desforges C; Sussman NM
    Epilepsia; 1995 Nov; 36(11):1111-7. PubMed ID: 7588455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and causes for failure of treatment of women with proven osteoporosis.
    Zafran N; Liss Z; Peled R; Sherf M; Reuveni H
    Osteoporos Int; 2005 Nov; 16(11):1375-83. PubMed ID: 15806322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of adherence to osteoporosis treatment in clinical practice.
    Rossini M; Bianchi G; Di Munno O; Giannini S; Minisola S; Sinigaglia L; Adami S;
    Osteoporos Int; 2006; 17(6):914-21. PubMed ID: 16538553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compliance of osteoporotic patients with different treatment regimens.
    Segal E; Tamir A; Ish-Shalom S
    Isr Med Assoc J; 2003 Dec; 5(12):859-62. PubMed ID: 14689753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring.
    Waterhouse DM; Calzone KA; Mele C; Brenner DE
    J Clin Oncol; 1993 Jun; 11(6):1189-97. PubMed ID: 8501505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.